2009•The Chinese Journal of Clinical PharmacologyRequires access

Study on pharmacokinetics of ursodexycholic acid in healthy volunteers by HPLC-MS/MS

Zhang Yi-di

Open publisher page 0 citations

Abstract

Objective To establish a HPLC-MS/MS method for determination of ursodexycholic acid in healthy human plasma and study on its pharmacokinetics in healthy human.Methods Twenty male healthy vounlteers were given a single oral dose of ursodexycholic acid 500 mg.Plasma concentrations were determined by HPLC-MS-MS method.The separation was carried out using the Shimadzu VP-ODS column with the mobile phase consisted of A: acetonitrile-H2O(35∶65);B: acetonitrile.The cetirizine was taken as the internal standard.And the plasma concentrations were detected in FSI negative selected ion monitoring mode.Results The standard curve was linear in range of 40.14~1.20×104 ng·mL-1(γ=0.995).The detection limited in the plasma was 40.14 ng·mL-1.RSD of intra-day and inter-day assays were all less than 20% in low concentrations,all less than 15% in middle or high concentrations,while the relativity recovery were 90.46%,86.51% and 93.41% respectively.The pharmacokinetic parameters were as follows:Cmax was(7.18±2.40) μg·mL-1,tmax was(2.80±0.90)h,AUC0-10 was(22.72±6.08)μg·h·mL-1,AUC0-∞ was(23.80±7.60)μg·h·mL-1.Conclusion HPLC-MS/MS method is selective,sensitive and convenient,proved to be suitable for determining concentration of ursodexycholic acid in plasma as well as pharmacokinetics studies.

About this research paper

What this paper is about

Objective To establish a HPLC-MS/MS method for determination of ursodexycholic acid in healthy human plasma and study on its pharmacokinetics in healthy human.Methods Twenty male healthy vounlteers were given a single oral dose of ursodexycholic acid 500 mg.Plasma concentrations were determined by HPLC-MS-MS method.The separation was carried out using the Shimadzu VP-ODS column with the mobile phase consisted of A: acetonitrile-H2O(35∶65);B: acetonitrile.The cetirizine was taken as the internal standard.And the plasma concentrations were detected in FSI negative selected ion monitoring mode.Results The standard curve was linear in range of 40.14~1.20×104 ng·mL-1(γ=0.995).The detection limited in the plasma was 40.14 ng·mL-1.RSD of intra-day and inter-day assays were all less than 20% in low concentrations,all less than 15% in middle or high concentrations,while the relativity recovery were 90.46%,86.51% and 93.41% respectively.The pharmacokinetic parameters were as follows:Cmax was(7.18±2.40) μg·mL-1,tmax was(2.80±0.90)h,AUC0-10 was(22.72±6.08)μg·h·mL-1,AUC0-∞ was(23.80±7.60)μg·h·mL-1.Conclusion HPLC-MS/MS method is selective,sensitive and convenient,proved to be suitable for determining concentration of ursodexycholic acid in plasma as well as pharmacokinetics studies.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To establish a HPLC-MS/MS method for determination of ursodexycholic acid in healthy human plasma and study on its pharmacokinetics in healthy human.Methods Twenty male healthy vounlteers were given a single oral dose of ursodexycholic acid 500 mg.Plasma concentrations were determined by HPLC-MS-MS method.The separation was carried out using the Shimadzu VP-ODS column with the mobile phase consisted of A: acetonitrile-H2O(35∶65);B: acetonitrile.The cetirizine was taken as the internal standard.And the plasma concentrations were detected in FSI negative selected ion monitoring mode.Results The standard curve was linear in range of 40.14~1.20×104 ng·mL-1(γ=0.995).The detection limited in the plasma was 40.14 ng·mL-1.RSD of intra-day and inter-day assays were all less than 20% in low concentrations,all less than 15% in middle or high concentrations,while the relativity recovery were 90.46%,86.51% and 93.41% respectively.The pharmacokinetic parameters were as follows:Cmax was(7.18±2.40) μg·mL-1,tmax was(2.80±0.90)h,AUC0-10 was(22.72±6.08)μg·h·mL-1,AUC0-∞ was(23.80±7.60)μg·h·mL-1.Conclusion HPLC-MS/MS method is selective,sensitive and convenient,proved to be suitable for determining concentration of ursodexycholic acid in plasma as well as pharmacokinetics studies.

Key concepts: Pharmacokinetics, Chromatography, Cmax, High-performance liquid chromatography, Chemistry, Acetonitrile, Plasma concentration, Human plasma

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pharmacokinetics of ursodexycholic acid in healthy volunteers by HPLC-MS/MS — Research Paper | ScholarLens